Bartolo Colon’s success is really bothering some people

73 Comments

Bartolo Colon has pitched magnificently this season. He leads the AL in wins, is sporting a 2.89 ERA and is pounding the strike zone like crazy, allowing only one walk per every nine innings pitched. This, apparently, is something baseball should be embarrassed by. Why? Because he tested positive for synthetic testosterone last year  Paul Gackle of the San Francisco Examiner:

If the deadline for submitting the All-Star Game rosters were today, Colon should be a shoe-in to make the American League pitching staff, which would be colossal embarrassment for the commissioner’s office. It would suggest one of two things: PEDs don’t, in fact, enhance athletic performances, so what’s the big deal? Or he’s still cheating and he’s beating the system.

But let’s be clear here. Gackle is not seriously entertaining the former option:

Baseball wants us to believe that it’s capable of tidying up the sport, putting an end to the guessing game over who is cheating and who is clean. It caught Colon, Melky Cabrera and another 18 players connected to a Miami-area clinic, and those players reportedly could be suspended in the next few weeks. Colon’s season is, however, raising more doubt over whether testing can keep pace with the evolution of PEDs.

Let’s be clear, I’m not accusing Colon of cheating. He could be another rubber arm, like Nolan Ryan and Randy Johnson, as far as I’m concerned. But I will say that his performance is evidence that 50-game suspensions won’t cut it if baseball really wants to crack down on PED users.

No, he is accusing Colon of cheating. By definition he is, for the direct conclusion he draws from Colon’s success this year is that baseball’s drug testing doesn’t work and that Colon’s success is an embarrassment and then spends time comparing Colon to Pete Rose and the game-throwers of the Chicago Black Sox and proposes suspending players for two years for PEDs.

Look, I have no idea what Bartolo Colon is doing to be successful in 2013. But It’s not like he wasn’t a top-flight pitcher for many, many years before shoulder problems derailed him. A late-career bump — especially one that isn’t accompanied by some massive increase in velocity and an uptick in strikeout rates — is not anything historically unprecedented. The notion that he’s back on banned substances and eluding drug testing is not impossible, but it is an argument that requires more evidence than other possible explanations such as “good pitcher has good season” or “synthetic testosterone is not some magic super power-bestowing substance,” or “throwing pitches in the strike zone and relying on your defense is good strategy.”

Gackle has no interest in marshaling any such evidence, however. He, like so many others, is merely interested in turning a somewhat complex matter of science and biology, turning it into a matter of good and evil and thus taking the laziest possible approach in order to get his column inches in.

Blue Jays acquire Randal Grichuk from the Cardinals

Jon Durr/Getty Images
2 Comments

The Blue Jays announced on Friday that the club acquired outfielder Randal Grichuk from the Cardinals in exchange for pitcher Dominic Leone and minor league pitcher Conner Greene.

Grichuk, 26, became expendable when the Cardinals acquired Marcell Ozuna from the Marlins. With veteran Dexter Fowler in right field and Tommy Pham — who finished 11th in NL MVP Award balloting last season — in center, Grichuk was effectively pushed to the bench. He will get a shot at regular playing time in an outfield corner with the Jays. Grichuk has had solid numbers since debuting in 2014, but he hasn’t been able to recapture the magic of his 2015 campaign. Last year, he hit .238/.285/.473 with 22 home runs and 59 RBI in 442 plate appearances.

Grichuk will earn $2.8 million this season and will be eligible for arbitration for two more years before becoming a free agent.

Leone, 26, posted an impressive 2.56 ERA with an 81/23 K/BB ratio across 70 1/3 innings last season. The right-hander will earn $1.085 million this season and then will become arbitration-eligible for the next three years. Leone certainly helps bolster the Cardinals’ bullpen and may work his way up to high-leverage innings behind closer Luke Gregerson.

Greene, 22, was selected by the Blue Jays in the seventh round of the 2013 draft. This past season, with Double-A New Hampshire, Greene compiled a 5.29 ERA with a 92/83 K/BB ratio in 132 2/3 innings. He throws hard, but control has been a big issue for the right-hander throughout his minor league career. The Cardinals may think they can help turn him around.